Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Retained Earnings (2023 - 2025)

Beta Bionics' Retained Earnings history spans 3 years, with the latest figure at $403000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 100.14% year-over-year to $403000.0; the TTM value through Dec 2025 reached $403000.0, up 100.14%, while the annual FY2025 figure was $403000.0, 100.14% up from the prior year.
  • Retained Earnings for Q4 2025 was $403000.0 at Beta Bionics, up from -$356.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $403000.0 in Q4 2025 and bottomed at -$356.5 million in Q3 2025.
  • The 3-year median for Retained Earnings is -$311.1 million (2024), against an average of -$220.1 million.
  • The largest annual shift saw Retained Earnings plummeted 216696.35% in 2024 before it surged 100.14% in 2025.
  • A 3-year view of Retained Earnings shows it stood at $137000.0 in 2023, then tumbled by 216696.35% to -$296.7 million in 2024, then soared by 100.14% to $403000.0 in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Retained Earnings are $403000.0 (Q4 2025), -$356.5 million (Q3 2025), and -$342.3 million (Q2 2025).